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Abstract The biological functions of plasma membranes depend
greatly on the biophysical properties resulting from protein and
phospholipid structure. We investigated the phospholipid struc-
ture of the normal sarcolemma membrane, which is known to be
highly dysfunctional in myopathies. Combining electron micros-
copy and 31P nuclear magnetic resonance (NMR) spectroscopy
on isolated sarcolemma vesicles, we find that (i) the sarcolemma
vesicles maintain the in-vivo cellular sidedness, (ii) the phospho-
lipid mobility is close to that observed in model membranes
(similar lateral diffusion coefficients and spin^lattice T1 relaxa-
tion times). Using broad-band and magic angle spinning 31P
NMR spectroscopy with lanthanide ions (Pr3+), it is possible to
quantify the distribution of phospholipids between internal and
external membrane layers, showing that the trans-bilayer
distribution is highly asymmetrical. ß 2001 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
Profound dysfunction and disruption of the plasma mem-
brane occur in the skeletal muscle of subjects with myopathy
due to a disease process a¡ecting the protein composition of
skeletal muscle sarcolemma or subsarcolemma [1,2]. Although
protein^protein interactions have been widely investigated in
the skeletal muscle plasma membrane, little is known about
the phospholipid (PL) structure and particularly the trans-bi-
layer distribution.
As a rule, all eukaryotic cells are now thought to exhibit an
asymmetrical trans-bilayer distribution of lipids [3^6]. This
lipid topology was ¢rst demonstrated in the human erythro-
cyte plasma membrane and later in several other types of cell ;
it appears to be essential for maintaining membrane proper-
ties and functions [7^9]. A range of indirect methods has been
used to determine the lipid distribution in these natural mem-
branes [10^12].
In the case of model membranes such as liposomes, a very
popular and widely developed strategy is to use paramagnetic
chemical shift reagents and nuclear magnetic resonance
(NMR) spectroscopy [13^23]. The distribution of PLs between
the two layers of the model membrane has been investigated
with NMR spectroscopy using Pr3, Dy3 and Eu3 para-
magnetic ions. These lanthanide ions induce a chemical shift
and/or a broadening of NMR lines, but they do not penetrate
into the membrane [16^18,21^23]. Apart from one report [24],
this strategy has only been performed on the type of model
membrane that yields high-resolution 31P NMR spectra, i.e.
small unilamellar vesicles (SUVs). In other model membranes
such as multilamellar vesicles, membrane lipids undergo a
slow isotropic motion on the NMR time scale. As this motion
cannot average the chemical shift anisotropy (CSA) of the
phosphorus nuclei, unresolved powder-like 31P NMR spec-
trum appear. The same applies for subcellular preparations
of sealed vesicles.
Magic angle spinning (MAS) NMR spectroscopy o¡ers new
possibilities for investigating membrane structure because it
can overcome the problem of unresolved spectra. This is
done by averaging the CSA, yielding narrow lines [25^27]
that are relatively easy to analyse and quantify [28,29].
In a previous study, we have shown that MAS 31P NMR
spectroscopy can identify the PLs in sarcolemma vesicles iso-
lated from normal rabbit skeletal muscle [30]. In order to
characterise the arrangement of sarcolemma PLs in more de-
tail, we now apply a strategy combining electron microscopy
and 31P NMR spectroscopy with lanthanide ions. In a ¢rst
step, electron microscopy allows us to check vesicle formation
and membrane sidedness. Then, solid-state and MAS 31P
NMR spectroscopy using lanthanide ions provides informa-
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tion about the trans-bilayer distribution of the membrane
PLs.
2. Materials and methods
2.1. Sarcolemma membranes
Sarcolemma membranes from New Zealand white rabbit skeletal
muscle (CEGAV Society, France) were isolated as previously de-
scribed [30,34]. Brie£y, the skeletal muscle was homogenised in bu¡er
A (20 mM sodium pyrophosphate, 20 mM sodium phosphate, 1 mM
MgCl2, 0.303 M sucrose, 0.5 mM EDTA, pH 7.0 and protease inhib-
itors). The homogenate was subjected to di¡erential centrifugation
steps and the resultant light microsomes were then loaded onto a
sucrose gradient and centrifuged at 104 000Ug for 17 h at 4‡C. The
¢nal preparation was obtained in bu¡er B (0.303 M sucrose, 20 mM
Tris^maleate, pH 7.0, and protease inhibitors), corresponding to a
protein concentration of about 50 mg/ml.
2.2. Transmission electron microscopy
2.2.1. Ultrathin sections. Sarcolemma vesicles were visualised as
previously described [30]. To summarize, ultrathin sections were cut
from embedded pellets of vesicles, stained with uranyl acetate and
lead citrate, and then observed under a JEOL electron microscope
(JEOL Europe, SA) operating at 80 kV.
The diameter of the vesicles was measured manually on micro-
graphs having the same magni¢cation of samples with or without
PrCl3. To some extent, the diameter seems to be preparation depen-
dent and values are expressed in the text as ranges.
2.2.2. Immunolocalisation of dystrophin and K-dystroglycan. Fresh-
ly isolated sarcolemma vesicles (four di¡erent preparations) were de-
posited on collodion carbon-coated nickel grids and incubated in 1%
bovine serum albumin (BSA) in phosphate-bu¡ered saline (PBS) for
2 h at room temperature. Vesicles were then incubated for 2 h with
primary monoclonal mouse anti-dystrophin (1:100 dilution, Sigma) or
anti-K-dystroglycan (1:500 dilution, Euromedex) antibodies, rinsed
three times with PBS^BSA, and incubated for 1 h with a 10-nm
GAM-gold secondary antibody (TEBU, France) diluted 40-fold in
PBS^BSA. After washing, the grids were stained with 2% uranyl ace-
tate and viewed using a Philips CM12 microscope operating at 100 kV
[31].
2.3. 31P NMR spectroscopy
Sarcolemma vesicles at a concentration of about 50 mg/ml protein
were introduced into a 4-mm-diameter ceramic rotor with a volume of
100 Wl. Alternatively, the paramagnetic agent PrCl3 (0.5^10 mM) was
added to the exterior of the membrane vesicle before introduction into
the rotor. 31P NMR spectra were obtained at 121.9 or 202.4 MHz in
4-mm MAS probes on ASX300 and DMX500 Bruker spectrometers,
respectively (Bruker spectrospin, Wissembourg, France) at 25‡C using
a single 90‡ pulse sequence with 5 s repetition delay. Broad-band
spectra without or with proton decoupling were acquired using
10 000 scans, 5 Ws dwell-time, 100 kHz spectral width, 8K data points
and 41 ms acquisition time. At 8 kHz MAS, spectra were acquired
with or without proton decoupling using 1000^4000 scans, 10 Ws
dwell-time, 50 kHz spectral width and 16 K data points.
T1 longitudinal relaxation times were measured at 121.9 MHz at
25‡C, with 8 kHz MAS rate, using a progressive saturation pulse
sequence, for samples with or without PrCl3.
Before applying the Fourier transform, free induction decays were
treated with an exponential broadening of 100 and 5 Hz for static and
spinning samples, respectively. 85% H3PO4 was used as an external
standard for the 31P chemical shift.
2.4. 31P NMR spectral simulation and quanti¢cation
Deconvolution and quanti¢cation of the broad-band static and
high-resolution spectra (MAS NMR spectra) were performed by
CSA and Lorentzian/Gaussian peak-shape ¢tting with WinFit Soft-
ware (Bruker Spectrospin, Wissembourg, France) [30].
The simulation programme used for treating the broad-band static
spectrum was developed [32] and modi¢ed [33] to include vesicle size
distribution. The simulation procedure is described in detail in [33].
Here, we assume that an axially symmetric tensor represents the CSA
of the phosphate component of PLs in biological membranes. This is
due to the rapid motion of the PLs around the local normal of the
bilayer, with an e¡ective CSA value of 45 þ 5 ppm. Hence, the e¡ect
of vesicle size distribution can be taken into account in 31P NMR
spectra simulations by incorporating additional averaging procedures:
(i) the rotational di¡usion of the vesicles, with a characteristic corre-
lation time dt ; (ii) the lateral di¡usion of PLs along the curved sur-
faces, with a characteristic correlation time ddiff . We can introduce an
e¡ective characteristic time, de¢ned by the following expression:
1=d  1=d t  1=d diff  D=r2 Dt Ddiff 
where Dt = kT/8ZrR is the rotational di¡usion coe⁄cient of the
vesicles, R is the viscosity of the medium and r the radius of the
vesicle. In our simulation programme, the distribution of the radius
values is represented by particular size-distribution pro¢les. The fol-
lowing values were used in the simulations: T = 298 K, Ddiff = 1037
cm2/s and R= 7.808U1034 P [32,33].
3. Results
3.1. Electron microscopy of sarcolemma vesicles
Electron microscopy shows that PrCl3 added at the exterior
of the vesicles induces some vesicle aggregation, but no fusion
is observed. Diameters of 200^250 nm and 230^290 nm are
obtained without and with PrCl3, respectively (Fig. 1).
3.2. Do the vesicles maintain cellular sidedness?
After using the Western blot method to check for the pres-
ence of dystrophin (an intracellular subsarcolemma protein)
or K-dystroglycan (an extracellular matrix protein) in the sar-
colemma vesicles (data not shown), we carried out immuno-
gold-labelling of each of these proteins in the vesicle mem-
branes (Fig. 2). The presence of gold particles as dark
spheres on the micrographs indirectly indicates labelling of
the corresponding protein. On the micrographs obtained
from immuno-labelling with K-dystroglycan, gold particles
are observed on the periphery of vesicles, indicating that
K-dystroglycan is present at the outer rim of these vesicles
(Fig. 2A). On the contrary, no gold particles were observed
on the micrographs obtained from immuno-labelling with dys-
trophin (Fig. 2B). This indicates that dystrophin is not present
on the vesicle rims, but is rather located inside the vesicles.
Fig. 1. Ultrathin electron microscopy sections of sarcolemma
vesicles from (A) control preparations and (B) from preparations in
contact with 5 mM PrCl3. Scale bar: 1 Wm
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Alternatively, dystrophin could be undetectable by immuno-
labelling even if present. When immunogold labelling is per-
formed on sonicated vesicles, gold particles are observed for
both proteins in many of the fragments (Fig. 2C,D). This
demonstrates that dystrophin is not located on the outer
side but only on the inner side of intact sarcolemma vesicles.
From these experiments, it appears that the vesicle mem-
branes maintain cellular sidedness with dystrophin inside the
vesicle and K-dystroglycan at the outer side.
3.3. Broad-band 31P NMR spectra of sarcolemma vesicles
As previously observed, the experimental broad-band 31P
NMR spectrum of the sarcolemma vesicles is predominantly
powder-like, characteristic of relatively large vesicles made up
of PLs in a bilayer arrangement (Fig. 3) [30,33]. When com-
paring non-proton-decoupled (Fig. 3A) and proton-decoupled
(Fig. 3B) spectra, the high-¢eld peak is slightly better resolved
with decoupling, but the CSA values are similar in both spec-
tra (42 ppm). This experiment shows there is no drastic in£u-
ence of the hetero-nuclear dipolar interaction on the line-
shape of the spectrum at high ¢eld.
Two narrow resonances at 2 ppm and 37.1 ppm were as-
signed to phosphorus nuclei from inorganic phosphorus and
sodium pyrophosphate, respectively, present in the homogeni-
sation bu¡er A [30]. Small £uctuations of the amount of in-
organic phosphorus and sodium pyrophosphate were ob-
served in various preparations.
To simulate the spectrum, several types of size distribution
were tested. Within each type of pro¢le, we varied the param-
eters to ¢t experimental and simulated spectra by comparing
the integrals of the spectra normalised to the same maximum
intensity (Fig. 4) [33]. The best-simulated spectrum is obtained
by assuming a Gaussian distribution of unilamellar vesicle size
with an average diameter of 250 þ 70 nm, which is in the same
range of size determined by electron microscopy. A good
agreement was obtained between NMR and electron micros-
copy to determine vesicle mean diameters using Ddiff = 1037
cm2/s, a result which is consistent with the £uid state of the
vesicle membrane.
Fig. 2. Immunogold-labelling electron microscopy of (A,C) K-dys-
troglycan and (B,D) dystrophin in (A,B) intact and (B,D) sonicated
sarcolemma vesicles (examples from four identical experiments). An
arrow indicates the presence of a gold particle. Scale bar: 0.5 Wm.
Fig. 3. (A) Experimental non-decoupled and (B) proton decoupled
broad-band 31P NMR spectra of sarcolemma vesicles performed at
202 MHz. c== and cP are the chemical shift anisotropy tensors.
Fig. 4. (A) Experimental and (B) simulated broad-band 31P NMR
spectra of sarcolemma vesicles performed at 121 MHz.
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3.4. E¡ect of PrCl3 on 31P NMR spectra of sarcolemma
vesicles
As previously observed [30], the 31P NMR MAS spectrum
of sarcolemma vesicles is made up of two major narrow res-
onances (Fig. 5A): the resonance at 30.63 ppm is from the
phosphorus nuclei of phosphatidylcholine (PLPC) and the res-
onance at 30.07 ppm is from the phosphorus nuclei of major
PLs other than phosphatidylcholine (PLnotPC). The minor res-
onance at 2 ppm (* in Fig. 5A) is from inorganic phosphorus
present in bu¡er A.
After the ¢rst addition of PrCl3 to the vesicle exterior, a
broad down¢eld resonance is observed amounting for about
50% of the total PLs. The two narrow resonances remain at
the same chemical shifts, but their intensities are modi¢ed.
Increasing concentrations of PrCl3 lead to a progressive
down¢eld shift of the broad resonance, whereas the relative
intensities of all the PL resonances remain constant (Fig. 5B^
E). The shifted signal (PLshifted) corresponds to PLs located on
the outer side of the vesicle membranes, which may be in
contact with Pr3 ions. By contrast, the unshifted signals rep-
resent the portion of PLPC and PLnotPC located within the
internal layer. For a full quantitative analysis, see below.
31P NMR spectra obtained over three consecutive days fol-
lowing the addition of 5 mM PrCl3 are identical to the initial
spectrum (data not shown). Moreover, identical results are
obtained for sarcolemma vesicles incubated with 5 mM PrCl3
at 1, 2 and 3 days after the isolation procedure.
Comparing the broad-band 31P NMR spectrum without
PrCl3 (Fig. 3A) with the broad-band 31P NMR spectrum
with PrCl3 (Fig. 6A), we observe an additional very intense
broad resonance at 16 ppm in the latter. This band accounts
for about half of the PLs. Using the same strategy of assign-
ment as for MAS spectra, this signal is assigned to PLs of the
external layer in contact with Pr3 ions. Assuming a mixed
Lorentzian and Gaussian deconvolution for this symmetric
band, the high-¢eld resonance is well-¢tted using a powder-
like peak shape (Fig. 6). Proton decoupling has no e¡ect on
the peak shape of spectra acquired with PrCl3 (Fig. 6).
Furthermore, the integrity of membrane vesicles at all PrCl3
concentrations is demonstrated by the constant resonance lev-
el of inorganic phosphate. This con¢rms that these paramag-
netic ions do not penetrate into the vesicles.
3.5. Trans-bilayer PL distribution in the vesicle membranes
In the absence of PrCl3 in ¢ve identical experiments, the
PLPC and PLnotPC resonances represented 66 þ 4 and 34 þ 4%
of the total PLs, respectively (Fig. 5A).
The quantitative analyses of PLshifted, PLPC and PLnotPC
resonances in the presence of PrCl3 are reported on the spec-
trum in Fig. 5D. The broad-shifted resonance represents
Fig. 5. 8 kHz MAS 31P NMR spectra of sarcolemma vesicles (A)
without PrCl3 and (B^E) in the presence of 1, 2, 3 and 5 mM PrCl3
performed at 202 MHz.
Fig. 6. (A) Experimental non-decoupled and (B) proton decoupled
broad-band 31P NMR spectrum of sarcolemma vesicles, performed
at 202 MHz with 5 mM PrCl3, using the narrow line ¢ts obtained
with WinFit software (see text).
Table 1
Calculated compositions of PLPC and PLnotPC for internal and exter-
nal layers of the vesicle membrane (expressed as a percentage of to-
tal PLs)
Internal layer External layera
PLPC 17.5 48.5
PLnotPC 32.5 1.5
a(PL)external = (PL)without PrCl33(PL)internal
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roughly 50% of the total intensity, while PLPC and PLnotPC
resonances in ¢ve identical experiments represent 35 þ 4 and
65 þ 4% of the unshifted resonances, respectively. Hence,
knowing the proportion of PLs in the internal layer and as-
suming that they represented about 50% of total PLs, PLPC
and PLnotPC levels in the internal layer correspond to 17.5 and
32.5% of the total PLs. We can then calculate the PLnotPC and
PLPC composition of the external layer of the vesicle mem-
brane (Table 1). It is clear that these two classes of PLs are
distributed asymmetrically between the two layers of the
vesicle membrane. The proportion of phosphatidylcholine is
very high in the external layer, while the other PLs are pref-
erentially located in the internal layer of the vesicle mem-
brane.
3.6. T1 longitudinal relaxation time measurements
The relaxation time T1 measured on PLPC and PLnotPC lines
on samples without PrCl3 are 1.00 þ 0.06 s and 0.96 þ 0.05 s in
six identical experiments, respectively. T1 on samples with
PrCl3 are found to be 0.97 þ 0.12 s and 1.15 þ 0.15 s for the
unshifted PLPC and PLnotPC lines in three identical experi-
ments, respectively. These values are similar to those obtained
on the same lines without PrCl3.
4. Discussion and conclusion
In this study, we combine two methods ^ 31P NMR spec-
troscopy and electron microscopy ^ to investigate the struc-
tural arrangement and dynamics of PLs in the isolated sarco-
lemma membrane of normal skeletal muscle.
We show, by immuno-labelling, that vesicle sarcolemma
membranes maintain the natural orientation of in-vivo muscle
cells, i.e. the internal layer of muscle cell membranes is found
only inside the vesicle membranes, despite the long isolation
procedure. This result gives great biological relevance to the
NMR ¢ndings. We also show that the motions are quite sim-
ilar in natural sarcolemma membrane compared with model
membranes [33,35^37]. This is based on peak-shape simula-
tions of broad-band spectra that yield information about slow
motions (speci¢cally, lateral di¡usion) and on T1 relaxation
time measurements which provide more detailed information
about rapid motions on short time scales.
By combining static and MAS 31P NMR spectroscopy with
lanthanide ions, we are able to achieve a simple and relatively
accurate method for studying the trans-bilayer PL distribution
without modifying the membrane. In the case of model mem-
branes [16^18,21^23], our NMR results show that: (1) sarco-
lemma membranes are impermeable to Pr3 ions because no
spectral change is observed after incubation for 3 days, while
the ratio of external to internal PLs remains constant. Fur-
thermore, T1 relaxation times of the internal PLs are not
modi¢ed by the presence of Pr3 ions; (2) at various PrCl3
concentrations, the presence of a single progressively shifted
resonance indicates a rapid exchange rate on the NMR time
scale between the paramagnetic ions and the lipid head-groups
of the external layer; (3) after sonication, all PLs are able to
interact with Pr3 ions since all phosphorus NMR signals are
shifted down¢eld.
Brown and Seelig [20] observed a reversal in the sign of the
CSA on addition of Eu3 to liposomes, together with a large
chemical shift. These authors suggested that a reorientation of
the lipid head-groups could produce a reversal in the sign of
the CSA. In the present study, we recorded no such modi¢-
cation. Instead, a second large symmetrical peak appeared,
strongly down¢eld-shifted and corresponding to about half
of the total PLs. This broad symmetrical peak shape is due
to the strong interaction between the electronic spin of the
Pr3 and the magnetic spin of the phosphorus nucleus, which
dominates the interaction of its magnetic spin with the static
magnetic ¢eld B0, i.e. the CSA. This strong interaction could
not be averaged by MAS and the peak-width appeared
roughly the same in the broad-band as in the MAS spectrum.
Using MAS 31P NMR spectroscopy with PrCl3, we were
also able to distinguish internal from external PLs in the nat-
ural membrane and quantify the phosphatidylcholine distribu-
tion between the two layers. It appears that the sarcolemma
PLs of skeletal muscle are distributed asymmetrically between
the two layers and, as in other cell types, phosphatidylcholine
is preferentially located in the external layer [5,6].
Previous studies on model membranes showed that lipids in
SUVs are asymmetrically distributed due to packing con-
straints and electrostatic repulsion between charged lipids.
However, the asymmetry tends to decrease as the vesicle size
increases [14,38,39]. The diameter of the sarcolemma vesicles
(W250 nm) in our study corresponds to the minimum size
that could be obtained without the physical constraints of
sonication, ¢ltration or freeze/thaw [33]. Therefore, at the mo-
lecular level, the bilayer in the vesicle membrane can be con-
sidered as £at [40]. Nevertheless, PLs are distributed asym-
metrically, suggesting that another e¡ect could play an
important role in their distribution and preservation.
Among other mechanisms involved in the preservation of
asymmetry, workers have suggested the action of peripheral
or integral proteins [41,42]. Since the vesicle membrane is
sealed inside-in, i.e. with dystrophin inside the vesicles, we
could argue that this protein participates in the preservation
of the trans-bilayer asymmetrical distribution of PLs as well
as their natural curvature [43]. In support of this idea, a high
a⁄nity has already been described between dystrophin and
anionic PLs [44]. Furthermore, it is known that dystrophin
is lacking and the plasma membrane is profoundly modi¢ed
in Duchenne muscular dystrophy [1,2]. In particular, the an-
chorage of integral proteins interacting with dystrophin does
not take place. However, the PL structure in the sarcolemma
of such pathological muscles has not yet been investigated.
Studies currently in progress should provide important data
supporting this hypothesis.
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